Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis : American Journal of Therapeutics

Secondary Logo

Journal Logo

Letters to the Editor

Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis

Abdulsattar, Waleed MD1; Beran, Azizullah MD1; Alqahtani, Ali MD2; Abuhelwa, Ziad MD1; Mhanna, Mohammed MD1; Alloghbi, Abdurahman MD3; Srour, Omar MD1; Ayesh, Hazem MD1; Hamouda, Danae MD4

Author Information
American Journal of Therapeutics 29(5):p e589-e592, September/October 2022. | DOI: 10.1097/MJT.0000000000001419
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid